PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report
- 19E83804-CF97-4779-A8F7-843EA896C524
- Pages: 40
- August 2018
- Total Views:1197
- Region : North America
- MarketLine
- Equity Research Report

Details
PDL Biopharma, Inc.-Strategy, SWOT and Corporate Finance Report
Summary
PDL Biopharma, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
PDL Biopharma, Inc., (PDL or 'the company'), formerly known as Protein Design Labs, Inc., is engaged in the research and development of humanized antibodies for cancer, immunologic diseases and other medical conditions. The company operates in the US, where it is headquartered in Incline Village, Nevada.
Scope
- Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments
- Intelligence on PDL Biopharma, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on PDL Biopharma, Inc.'s business structure, strategy and prospects.
Table Of Content
Scope
Table of Contents
Company Snapshot 2
Table of Contents 5
PDL Biopharma, Inc.: Company Overview 9
PDL Biopharma, Inc.: Overview and Key Facts 9
PDL Biopharma, Inc.: Overview 9
PDL Biopharma, Inc.: Key Facts 9
PDL Biopharma, Inc.: Key Employees 11
PDL Biopharma, Inc.: Key Employee Biographies 12
PDL Biopharma, Inc.: Major Products and Services 16
PDL Biopharma, Inc.: Company History 17
PDL Biopharma, Inc.: Management Statement 20
PDL Biopharma, Inc.: Locations and Subsidiaries 21
PDL Biopharma, Inc.: Key Competitors 22
PDL Biopharma, Inc.: Company Analysis 23
PDL Biopharma, Inc.: Business Description 23
PDL Biopharma, Inc.: SWOT Analysis 24
PDL Biopharma, Inc.: SWOT Overview 24
PDL Biopharma, Inc.: Strengths 24
PDL Biopharma, Inc.: Weaknesses 24
PDL Biopharma, Inc.: Opportunities 25
PDL Biopharma, Inc.: Threats 26
PDL Biopharma, Inc.: Corporate Financial Deals Activity 27
PDL Biopharma, Inc.: Financial Deals Overview 27
PDL Biopharma, Inc.: Top Deals 2014-2018YTD 29
PDL Biopharma, Inc.: Mergers and Acquisitions 30
PDL Biopharma, Inc.: Recent Developments 31
PDL Biopharma, Inc.: News and Events Summary 31
PDL Biopharma, Inc.: Business Expansion 33
PDL Biopharma, Inc.: Corporate Governance 34
PDL Biopharma, Inc.: Financial Deals 34
PDL Biopharma, Inc.: Financial Performance 35
PDL Biopharma, Inc.: Red Flags/DistressSignals 36
PDL Biopharma, Inc.: Regulatory and Legal Events 36
PDL Biopharma, Inc.: Strategy and Operations 37
Appendix 38
Contact Us 38
Methodology 38
About MarketLine 39
List Of Figure
List of Figures
Figure 1: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (TTM )
Figure 2: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)
Figure 3: PDL Biopharma, Inc.: M&A Average Deal Size-Value (USD m)
Figure 4: PDL Biopharma, Inc.: M&A Volume and Value Trend (2014-YTD 2018)
List Of Table
List of Tables
Table 1: PDL Biopharma, Inc.: Key Facts
Table 2: PDL Biopharma, Inc.: Key Employees
Table 3: PDL Biopharma, Inc.: Locations and Subsidiaries
Table 4: PDL Biopharma, Inc.: Key Competitors
Table 5: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (TTM )
Table 6: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)
Table 7: PDL Biopharma, Inc.: M&A Average Deal Size-Value (USD m)
Table 8: PDL Biopharma, Inc.: Top Deals 2014-2018YTD
Table 9: PDL Biopharma, Inc.: M&A Volume and Value Trend (2014-YTD 2018)
Table 10: PDL Biopharma, Inc.: News and Events Summary
Table 11: PDL Biopharma, Inc.: Business Expansion
Table 12: PDL Biopharma, Inc.: Corporate Governance
Table 13: PDL Biopharma, Inc.: Financial Deals
Table 14: PDL Biopharma, Inc.: Financial Performance
Table 15: PDL Biopharma, Inc.: Red Flags/DistressSignals
Table 16: PDL Biopharma, Inc.: Regulatory and Legal Events
Table 17: PDL Biopharma, Inc.: Strategy and Operations
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Company Profile
Company Profile Title
PDL Biopharma, Inc.-Strategy, SWOT and Corporate Finance Report
Summary
PDL Biopharma, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
PDL Biopharma, Inc., (PDL or 'the company'), formerly known as Protein Design Labs, Inc., is engaged in the research and development of humanized antibodies for cancer, immunologic diseases and other medical conditions. The company operates in the US, where it is headquartered in Incline Village, Nevada.
Scope
- Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments
- Intelligence on PDL Biopharma, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on PDL Biopharma, Inc.'s business structure, strategy and prospects.
Scope
Table of Contents
Company Snapshot 2
Table of Contents 5
PDL Biopharma, Inc.: Company Overview 9
PDL Biopharma, Inc.: Overview and Key Facts 9
PDL Biopharma, Inc.: Overview 9
PDL Biopharma, Inc.: Key Facts 9
PDL Biopharma, Inc.: Key Employees 11
PDL Biopharma, Inc.: Key Employee Biographies 12
PDL Biopharma, Inc.: Major Products and Services 16
PDL Biopharma, Inc.: Company History 17
PDL Biopharma, Inc.: Management Statement 20
PDL Biopharma, Inc.: Locations and Subsidiaries 21
PDL Biopharma, Inc.: Key Competitors 22
PDL Biopharma, Inc.: Company Analysis 23
PDL Biopharma, Inc.: Business Description 23
PDL Biopharma, Inc.: SWOT Analysis 24
PDL Biopharma, Inc.: SWOT Overview 24
PDL Biopharma, Inc.: Strengths 24
PDL Biopharma, Inc.: Weaknesses 24
PDL Biopharma, Inc.: Opportunities 25
PDL Biopharma, Inc.: Threats 26
PDL Biopharma, Inc.: Corporate Financial Deals Activity 27
PDL Biopharma, Inc.: Financial Deals Overview 27
PDL Biopharma, Inc.: Top Deals 2014-2018YTD 29
PDL Biopharma, Inc.: Mergers and Acquisitions 30
PDL Biopharma, Inc.: Recent Developments 31
PDL Biopharma, Inc.: News and Events Summary 31
PDL Biopharma, Inc.: Business Expansion 33
PDL Biopharma, Inc.: Corporate Governance 34
PDL Biopharma, Inc.: Financial Deals 34
PDL Biopharma, Inc.: Financial Performance 35
PDL Biopharma, Inc.: Red Flags/DistressSignals 36
PDL Biopharma, Inc.: Regulatory and Legal Events 36
PDL Biopharma, Inc.: Strategy and Operations 37
Appendix 38
Contact Us 38
Methodology 38
About MarketLine 39
List Of Figure
List of Figures
Figure 1: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (TTM )
Figure 2: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)
Figure 3: PDL Biopharma, Inc.: M&A Average Deal Size-Value (USD m)
Figure 4: PDL Biopharma, Inc.: M&A Volume and Value Trend (2014-YTD 2018)
List Of Table
List of Tables
Table 1: PDL Biopharma, Inc.: Key Facts
Table 2: PDL Biopharma, Inc.: Key Employees
Table 3: PDL Biopharma, Inc.: Locations and Subsidiaries
Table 4: PDL Biopharma, Inc.: Key Competitors
Table 5: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (TTM )
Table 6: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)
Table 7: PDL Biopharma, Inc.: M&A Average Deal Size-Value (USD m)
Table 8: PDL Biopharma, Inc.: Top Deals 2014-2018YTD
Table 9: PDL Biopharma, Inc.: M&A Volume and Value Trend (2014-YTD 2018)
Table 10: PDL Biopharma, Inc.: News and Events Summary
Table 11: PDL Biopharma, Inc.: Business Expansion
Table 12: PDL Biopharma, Inc.: Corporate Governance
Table 13: PDL Biopharma, Inc.: Financial Deals
Table 14: PDL Biopharma, Inc.: Financial Performance
Table 15: PDL Biopharma, Inc.: Red Flags/DistressSignals
Table 16: PDL Biopharma, Inc.: Regulatory and Legal Events
Table 17: PDL Biopharma, Inc.: Strategy and Operations
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company